Trial intelligence / Profile preview

PK Study of MGC-ODT vs Sativex in Healthy Volunteers

NCT03936907Phase 1Completed

Sponsor
One World Cannabis
Start
Apr 2019
Primary completion
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial in chronic pain and spasticity (2 arms), sponsored by One World Cannabis. Primary endpoints: Time to Maximum Plasma Concentration, Maximum Plasma Concentration and 4 more. Started Apr 2019; status: completed.

02

Conditions

chronic painspasticity

Beyond the preview

Go deeper on NCT03936907.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03936907.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call